← Open Payments lookup

MICHELLE GALPERIN: Open Payments

NPI 1184269904 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,626 in 67 payments from 7 companies in 2025. Trend: 2023 $914 · 2024 $822 · 2025 $1,626

Food & beverage: $1,626
CompanyPaymentsAmount
Janssen Biotech, Inc.20$835
ABBVIE INC.30$507
Takeda Pharmaceuticals U.S.A., Inc.13$204
Aimmune Therapeutics, Inc.1$26
Sandoz Inc.1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
Lilly USA, LLC1$14

Products named: TREMFYA, RINVOQ, ENTYVIO, SKYRIZI, VOWST, HYRIMOZ, XIFAXAN, OMVOH.

Industry payments across NY — which companies pay providers there.